相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, methylight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients
Veronique Quillien et al.
CANCER (2012)
MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
Annette Bentsen Havik et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma
Arne Christians et al.
PLOS ONE (2012)
O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction
Marta Brell et al.
BMC CANCER (2011)
Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients
Carmen Balana et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Extent and Patterns of MGMT Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres
Davide Sciuscio et al.
CLINICAL CANCER RESEARCH (2011)
Poor reliability and reproducibility of PCR-based testing of O6-methylguanine-DNA methyltransferase gene (MGMT) promoter methylation status in formalin-fixed and paraffin-embedded neurosurgical biopsy specimens
M. Preusser et al.
CLINICAL NEUROPATHOLOGY (2011)
Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma
Miyuki Uno et al.
CLINICS (2011)
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Albert Lai et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Quantitative analysis of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomas
Adrian F. Ochsenbein et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Primer extension based quantitative polymerase chain reaction reveals consistent differences in the methylation status of the MGMT promoter in diffusely infiltrating gliomas (WHO grade II-IV) of adults
Erik Vassella et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
O6-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation
Simone Kreth et al.
PLOS ONE (2011)
The Global DNA Methylation Surrogate LINE-1 Methylation Is Correlated with MGMT Promoter Methylation and Is a Better Prognostic Factor for Glioma
Fumiharu Ohka et al.
PLOS ONE (2011)
CHEMORADIOTHERAPY OF NEWLY DIAGNOSED GLIOBLASTOMA WITH INTENSIFIED TEMOZOLOMIDE
Markus Weiler et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
Roger Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
David M. Peereboom et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study
Alessandra Fabi et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller et al.
NATURE REVIEWS NEUROLOGY (2010)
MGMT promoter methylation in malignant gliomas
Markus J. Riemenschneider et al.
TARGETED ONCOLOGY (2010)
Long-term survivors of glioblastoma: clinical features and molecular analysis
Yukihiko Sonoda et al.
ACTA NEUROCHIRURGICA (2009)
Prognostic Impact of O6-Methylguanine-DNA Methyltransferase Silencing in Patients With Recurrent Glioblastoma Multiforme Who Undergo Surgery and Carmustine Wafer Implantation A Prospective Patient Cohort
Philippe Metellus et al.
CANCER (2009)
Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
Joerg Felsberg et al.
CLINICAL CANCER RESEARCH (2009)
Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial
Stuart A. Grossman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas
Sibille Everhard et al.
NEURO-ONCOLOGY (2009)
Promoter Methylation and Polymorphisms of the MGMT Gene in Glioblastomas: A Population-Based Study
Izabela Zawlik et al.
NEUROEPIDEMIOLOGY (2009)
Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas
Takao Nakagawa et al.
NEUROPATHOLOGY (2009)
THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND MGMT PROTEIN IN GLIOBLASTOMAS
Van Thang Cao et al.
NEUROSURGERY (2009)
Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma -: Relationship between immunohistochemistry and methylation analysis
Ken Sasai et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Molecular diagnostic testing in malignant gliomas: A practical update on predictive markers
Stephen Yip et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Variation of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma
Jonathon F. Parkinson et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach
David Capper et al.
ACTA NEUROPATHOLOGICA (2008)
Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas
Eva M. Grasbon-Frodl et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas
Judith Wm Jeuken et al.
LABORATORY INVESTIGATION (2007)
Novel mechanism whereby nuclear factor κB mediates DNA damage repair through regulation of O6-methylguanine-DNA-methyltransferase
Iris Lavon et al.
CANCER RESEARCH (2007)
MGMT hypermethylation: A prognostic foe, a predictive friend
Filipe V. Jacinto et al.
DNA REPAIR (2007)
Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide
Olivier L. Chinot et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells
Michael D. Blough et al.
CANCER RESEARCH (2007)
Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma
Jill A. Maxwell et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas
M Brell et al.
CLINICAL CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors
M Möllemann et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas
S Nakasu et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase, π in glioblastoma and the survival of the patients treated with nimustine hydrochloride:: An immunohistochemical analysis
T Anda et al.
NEUROLOGICAL RESEARCH (2003)
Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathway
MR Middleton et al.
LANCET ONCOLOGY (2003)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
